Brief: Oryzon 9-Month Net Loss At 2.3 Mln Euros
Oct 24 (Reuters) - Oryzon Genomics SA ORY.MC :
* 9-MONTH NET LOSS 2.3 MILLION EUROS
* 9-MONTH REVENUE FROM WORK ON OWN FIXED ASSETS 5.6 MILLION EUROS
Source text for Eikon: ID:nCNM15ctjx
Further company coverage: ORY.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on ORYZON Genomics SA
See all newsBrief: Oryzon Gets New Patent Grants For Vafidemstat In Four Countries
Brief: Oryzon Gets EMA Approval To Start Phase II Study Of Vafidemstat For PMS Treatment
Spanish stocks - Factors to watch on Aug 31
Brief: Oryzon Gets U.S. Patent Allowance For Iadademstat And Gilteritinib Drug Combo Application
Spanish stocks - Factors to watch on July 28